About LSVT Global!

About LSVT Global, Inc

LSVT Global is a socially responsible for-profit business with a vision for serving (through technology) the growing global population who require innovative speech therapy processes to communicate successfully.

LSVT Global operates a profitable business, training speech clinicians worldwide (over 5000 to date in 50 countries) in a research based, proprietary speech therapy approach invented by its founders. In turn, these clinicians have treated over 30,000 patients. Most recently, LSVT Global has begun to train physical and occupational therapists on a derivative of the speech treatment that is directed at improving the whole body movements of Parkinson patients.

Clinicians (through LSVT Global Workshops) are trained in the therapy and serve as an extended indirect global sales team to deploy technical product to patients. Additionally, LSVT will market directly to patients via Internet-based products. Training of occupational therapists, physical therapists and speech clinicians and the technology-supported treatment of patients are the products of LSVT Global.

LSVT Global’s business model and technical delivery mechanism enables rapid scale and global access to these life-changing methods. There is protected intellectual property; and market entry has been established.

LSVT Global has a loyal client base and outstanding spokespersons that endorse our products. Our work is well grounded in university research programs and market networks, both of which are certain to fuel continued growth.

Contact Information

Frank Shinneman

Frank Shinneman, has served as President and Chief Executive Officer of a number of high technology start-ups. He led Lamina Lighting, the highest power LED lighting producer, selling the company to Lighting Science Group. Prior to joining Lamina, Shinneman was president of PlasmaSol Corporation, the sale of which he successfully negotiated to Stryker Instruments in 2005. Mr. Shinneman was the founding CEO of Nanondyne, one of the first nano-materials companies,. Under his leadership, the company achieved commercial success and was sold to its major strategic partner, Umicore, where he assumed the role of U.S. business development, leading investments in a portfolio of technology companies.  In 2002, he led the financially struggling Moltech Corporation, an advanced lithium battery company, through reorganization to a successful sale to Hua Yi.  Previously, he served as Division President of Materials Research Corporation in Orangeburg, New York (now a part of Praxair).

Dr. Lorraine A. Ramig, Co-Founder

After her clinical training in Speech-Language Pathology, Dr. Ramig obtained a Doctorate in Speech Science from Purdue University. She currently holds the positions of Professor in the Department of Speech, Language and Hearing Science at the University of Colorado-Boulder, Senior Scientist at the National Center for Voice and Speech, Denver and Adjunct Professor at Columbia University, New York City. Dr. Ramig's research on voice treatment for Parkinson disease has been funded by the National Institutes of Health (NIH) for over 15 years. Dr. Ramig currently serves on the National Institutes of Health Advisory Council for the Institute of Deafness and Communication Disorders. She has over 25 years experience in teaching and student supervision at both the undergraduate and graduate levels. She also serves as editorial consultant and reviewer for several major U.S. and international scientific journals. She is widely published in scientific periodicals in speech, neurology and otolaryngology.

Dr. Ramig currently serves on the Scientific Advisory Board and Board of Directors for the Davis Phinney Foundation for Parkinson disease in Boulder, Colorado.

Dr. Ramig was born and raised in northern Wisconsin and currently resides in Boulder Colorado.

Dr. Cynthia Fox, Co-Founder

Dr. Fox received her doctorate degree in Speech and Hearing Sciences with a concentration in neuroscience and motor control from the University of Arizona, Tucson in 2002. Since then, her research focus has been in the area of neurological based speech and voice disorders, and she is among the world's experts in speech treatment for people with Parkinson disease and has published extensively in this area.

In addition to her long standing collaboration with Dr. Ramig, Dr. Fox has been instrumental to the application of LSVT®-LOUD to other disorders (children and adults) and other motor systems (e.g., limb). Dr. Fox has a keen interest in translating principles of exercise and motor training that have been shown to be neural protective or neural restorative in animal models of Parkinson disease to human studies of behavioral speech and physical treatments.

Dr. Fox's is research affiliations include the National Center for Voice and Speech, and the department of neurology at the University of Arizona, Tucson. She is co-Founder and Executive Vice President of the LSVT Foundation, a 501C3 organization which offers educational support to the Parkinson disease community and certifies speech clinicians in delivery of efficacious voice treatment for individuals with neurological disorders.

Dr. Fox is on the board of directors of the Arizona Chapter of the American Parkinson Disease Association in Tucson, AZ.

Dr. Fox was born and raised in the Midwest (southern Illinois) until her post-collegiate migration to the West/Southwest (currently Tucson, AZ).

Dr. David H. McFarland, Co-Founder

After his clinical training, Dr. McFarland obtained a Doctorate in Speech/Neuroscience from Purdue University, and completed his post-doctoral studies in Neurophysiology at the University of Montréal.

Dr. McFarland holds the position of Professor in the Faculty of Medicine at the University of Montréal, and his academic affiliations include a position as Adjunct Professor in the Faculty of Medicine of McGill University.

Dr. McFarland has over 25 years experience in teaching and student supervision at both the undergraduate and graduate levels. He also serves as editor and reviewer for several major Canadian and U.S. scientific journals and has published widely in several prestigious scientific periodicals. He is the author of a well-recognized reference book in anatomy and physiology.

In addition to his academic interests, Dr. McFarland also consults in the private sector, and from 2000 to 2003 served as Vice-President of Research and Development for Biotonix, Inc, a company providing internet-based, health assessment and treatment products and services. His responsibilities included research, product development, strategic positioning and change management associated with web-based postural assessment and correction tools used by medical and sports professionals. Dr. McFarland was also responsible for regulatory affairs and he supervised and co-authored several U.S., Canadian, and International Patents.

Continuing his focus on the healthcare sector, Dr. McFarland also served on the Research Academy and Advisory Board of the National Academy of Sports Medicine (NASM) and founded a Montreal-based scientific healthcare consulting firm, Consultation Scientifica.

Dr. McFarland hails originally from Long Beach, California and lives in Montréal, Québec, Canada.

Patents and Trademarks

Our products are both patent and copyright protected within North America and Internationally.

LSVT Intellectual Property - Our products are both patent and copyright protected within North America and Internationally and the LSVT® trademark and other logos appearing within LSVT’s website are registered and unregistered trademarks of LSVT Global, Inc.